[20] One previous report showed that high soluble CD200 (sCD200) correlated with advanced clinical stage and elevated β2-microglobulin in CLL and sCD200 was critical for engraft CLL cells in immunocompromised mice. The gene discussed is HLA-G; the disease is B-cell chronic lymphocytic leukemia.